Aztreonam in combination with imipenem-relebactam against clinical and isogenic strains of serine and metallo-β-lactamase-producing enterobacterales

Zidovudine enhances activity of carbapenems against NDM-1-producing Enterobacteriaceae

(2021) Yanmin Hu et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Epidemiology of β-Lactamase-Producing Pathogens

(2020) Karen Bush et al.   CLINICAL MICROBIOLOGY REVIEWS

Imipenem‐Cilastatin‐Relebactam: A Novel β‐Lactam–β‐Lactamase Inhibitor Combination for the Treatment of Multidrug‐Resistant Gram‐Negative Infections

(2020) Jordan R. Smith et al.   PHARMACOTHERAPY

Novel Cassette Assay To Quantify the Outer Membrane Permeability of Five β-Lactams Simultaneously in Carbapenem-Resistant Klebsiella pneumoniae and Enterobacter cloacae

(2020) Tae Hwan Kim et al.   mBio

Clinical Features and Outcomes of Bloodstream Infections Caused by New Delhi Metallo-β-Lactamase–Producing Enterobacterales During a Regional Outbreak

(2020) Marco Falcone et al.   Open Forum Infectious Diseases

Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study

(2020) Michelle L Brown et al.   Open Forum Infectious Diseases

Comparable Efficacy and Better Safety of Double β-Lactam Combination Therapy versus β-Lactam plus Aminoglycoside in Gram-negatives: A Meta-analysis of Randomized, Controlled Trials

(2019) Yuanyuan Jiao et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Searching for the Optimal Treatment for Metallo- and Serine-β-Lactamase Producing Enterobacteriaceae: Aztreonam in Combination with Ceftazidime-avibactam or Meropenem-vaborbactam

(2019) M Biagi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections

(2019) Johann Motsch et al.   CLINICAL INFECTIOUS DISEASES

Monitoring Ceftazidime-Avibactam and Aztreonam Concentrations in the Treatment of a Bloodstream Infection Caused by a Multidrug-Resistant Enterobacter sp. Carrying Both Klebsiella pneumoniae Carbapenemase–4 and New Delhi Metallo-β-Lactamase–1

(2019) Mohamad Yasmin et al.   CLINICAL INFECTIOUS DISEASES

First Penicillin-Binding Protein Occupancy Patterns of β-Lactams and β-Lactamase Inhibitors in Klebsiella pneumoniae

(2018) Dhruvitkumar S. Sutaria et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a β-Lactamase Inhibitor, in Combination With Imipenem and Cilastatin in Healthy Participants

(2018) Elizabeth G. Rhee et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Past and Present Perspectives on β-Lactamases

(2018) Karen Bush   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical outcomes after combination treatment with ceftazidime/avibactam and aztreonam for NDM-1/OXA-48/CTX-M-15-producing Klebsiella pneumoniae infection

(2017) Evelyn Shaw et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

CARD 2017: expansion and model-centric curation of the comprehensive antibiotic resistance database

(2016) Baofeng Jia et al.   NUCLEIC ACIDS RESEARCH

Rapid Induction of High-Level Carbapenem Resistance in Heteroresistant KPC-Producing Klebsiella pneumoniae

(2015) Sheila Adams-Sapper et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Identification of acquired antimicrobial resistance genes

(2012) E. Zankari et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing

(2012) Anton Bankevich et al.   JOURNAL OF COMPUTATIONAL BIOLOGY

Relative Strengths of the Class 1 Integron Promoter Hybrid 2 and the Combinations of Strong and Hybrid 1 with an Active P2 Promoter

(2008) C. C. Papagiannitsis et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY